Advanced Bio Convergence Center (ABCC), Pohang Technopark Foundation, Pohang, Gyeongbuk, 37668, Republic of Korea; School of Biotechnology, Yeungnam University, Gyeongsan, Gyeongbuk 712749, Republic of Korea.
Advanced Bio Convergence Center (ABCC), Pohang Technopark Foundation, Pohang, Gyeongbuk, 37668, Republic of Korea; Department of Biotechnology, Daegu University, Gyeongsan, 38453, Republic of Korea.
Phytomedicine. 2022 Jun;100:154037. doi: 10.1016/j.phymed.2022.154037. Epub 2022 Mar 22.
Moringa oleifera (M. oleifera) is cultivated throughout the world and it is known by numerous regional names and is consumed as medication for various diseases such as hypertension, diabetes, HIV and is potential source of nutrients and natural antioxidants making it among the most useful trees.
We evaluated the therapeutic potential of M. oleifera on ethanol-induced fatty liver. The mice were treated with 30% ethanol (EtOH) alone or in combination with different concentration of M. oleifera extracts (100, 200 and 400 mg/kg). We performed biochemical estimation for the serum of important liver damage markers such as aspartate aminotransferase (AST), alanine aminotransferase (ALT) and triglyceride (TG). We performed histopathological analysis from the liver tissues of different mice groups. We also performed ELISA assay, western blotting analysis and SPECT imaging to obtain our results.
The results for serum (AST, p < 0.0001), (ALT, p < 0.0006) and triglyceride (TG, p < 0.0003) were found to be significantly reduced in all doses of M. oleifera extract treatment groups in comparison with the ethanol group. H&E staining analysis and scoring revealed a significant reduction in lipid droplet accumulation and a significant reduction of liver steatosis (p < 0.0001), lobular inflammation (p < 0.0013), ballooning (p < 0.0004) and immunohistochemistry for TNF-α. M. oleifera also ameliorated ethanol-induced oxidative stress evaluated through MDA (p < 0.0001), HDCFDA, JC-1 staining and a significant down-regulation of CYP2E1 enzyme (p < 0.0001) in the 200 and 400 mg/kg groups in comparison with EtOH groups. M. oleifera extract also boosted the antioxidant response evaluated through total GSH assay (p < 0.0001) and nuclear translocation of Nrf2. Furthermore, we performed SPECT imaging and evaluated the liver uptake value (LUV) to assess the extent of liver damage. LUV was observed to be lower in the ethanol group, whereas LUV was higher in control and M. olifera treated groups.
In summary, from this experiment we conclude that M. oleifera extract has the potential to ameliorate ethanol-induced liver damage.
辣木(Moringa oleifera)在世界各地都有种植,它有许多地区名称,并被用作治疗高血压、糖尿病、艾滋病等各种疾病的药物,同时也是潜在的营养物质和天然抗氧化剂来源,是最有用的树木之一。
我们评估了辣木对乙醇诱导的脂肪肝的治疗潜力。将小鼠用 30%乙醇(EtOH)单独或与不同浓度的辣木提取物(100、200 和 400mg/kg)联合处理。我们对血清中重要的肝损伤标志物(如天冬氨酸转氨酶(AST)、丙氨酸转氨酶(ALT)和甘油三酯(TG))进行了生化评估。我们对不同小鼠组的肝组织进行了组织病理学分析。我们还进行了 ELISA 检测、Western blot 分析和 SPECT 成像来获得结果。
与乙醇组相比,所有剂量的辣木提取物处理组的血清(AST,p < 0.0001)、(ALT,p < 0.0006)和甘油三酯(TG,p < 0.0003)均显著降低。H&E 染色分析和评分显示,辣木提取物处理组的脂质滴积累显著减少,肝脂肪变性(p < 0.0001)、小叶炎症(p < 0.0013)、气球样变性(p < 0.0004)和 TNF-α的免疫组化显著减少。辣木提取物还通过 MDA(p < 0.0001)、HDCFDA、JC-1 染色评估了乙醇诱导的氧化应激,以及 CYP2E1 酶的显著下调(p < 0.0001),在 200 和 400mg/kg 组与 EtOH 组相比。辣木提取物还通过总 GSH 测定(p < 0.0001)和 Nrf2 的核易位来增强抗氧化反应。此外,我们进行了 SPECT 成像,并评估了肝摄取值(LUV)来评估肝损伤的程度。与对照组和辣木处理组相比,乙醇组的 LUV 较低,而对照组和辣木处理组的 LUV 较高。
总之,从这项实验中我们得出结论,辣木提取物具有改善乙醇诱导的肝损伤的潜力。